Skip to main content
. 2022 Nov 1;8(4):385–395. doi: 10.1007/s41030-022-00202-y

Table 1.

Demographic and Clinical Characteristics, by Mutation

Characteristic F/F (n = 11,916) F/RF (all) (n = 1242) P-valuea F/RF (excluding R117H) (n = 889) P-valueb
Age, years, mean (SD) 18.0 (9.6) 23.0 (12.1)  < 0.001 23.6 (11.8) < 0.001
Female, n (%) 5698 (47.8) 645 (51.9) 0.006 473 (53.2) 0.002
Height-for-age z-score, mean (SD) −0.49 (1.03) 0.04 (1.03) < 0.001  −0.01 (1.02) < 0.001
Weight-for-age z-score, mean (SD) −0.48 (1.11) 0.36 (1.14) < 0.001 0.29 (1.15) < 0.001
BMI-for-age z-score, mean (SD) −0.29 (1.08) 0.36 (1.09) < 0.001 0.29 (1.10) < 0.001
ppFEV1 at baseline visit, %, mean (SD) 73.4 (26.5) 80.4 (24.8) < 0.001 78.6 (25.3) < 0.001
Patients with positive microbiology n (%)c
 Staphylococcus aureus 5386 (45.2) 524 (42.2) 0.042 402 (45.2) 0.99
 Pseudomonas aeruginosa 4131 (34.7) 277 (22.3) < 0.001 234 (26.3) < 0.001
 Haemophilus influenzae 662 (5.6) 69 (5.6) 1.00 49 (5.5) 0.96
 Aspergillus species 688 (5.8) 42 (3.4) < 0.001 32 (3.6) 0.007
 Stenotrophomonas maltophilia 677 (5.7) 48 (3.9) 0.008 38 (4.3) 0.078
 Burkholderia cepacia 237 (2.0) 7 (0.6) < 0.001 7 (0.8) 0.012

BMI body mass index, F F508del, ppFEV1 percent predicted forced expiratory volume in 1 s, RF residual function

aF/F versus F/RF (all)

bF/F versus F/RF (excluding R117H)

cAt first visit in the 2-year period